5 Simple Statements About is nembutal a barbiturate Explained
5 Simple Statements About is nembutal a barbiturate Explained
Blog Article
pentobarbital decreases amounts of ponatinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Steer clear of Unless of course the coadministration outweighs the feasible chance of ponatinib underexposure; keep an eye on for indications of decreased efficacy.
pentobarbital will reduce the extent or outcome of bexarotene by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
pentobarbital will lessen the extent or outcome of atogepant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Carefully. Advisable atogepant dosage with concomitant utilization of solid or reasonable CYP3A4 inducers is thirty mg or sixty mg qDay.
pentobarbital will lower the level or result of oxybutynin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unknown.
pentobarbital will decrease the level or result of cariprazine by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lower the level or influence of irinotecan by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital will lessen the extent or impact of fentanyl transmucosal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Carefully. Coadministration of fentanyl with CYP3A4 inducers could lead to a minimize in fentanyl plasma concentrations, not enough efficacy or, maybe, enhancement of the withdrawal syndrome inside of a affected person who's got formulated Actual physical dependence to fentanyl.
pentobarbital will minimize the level or effect of etravirine by impacting hepatic enzyme CYP2C9/10 metabolism. Use Warning/Observe.
Keep track of Carefully (1)pentobarbital will decrease the extent or influence of levamlodipine website by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
펜토바르비탈은 라이 증후군의 두개내의 압력을 줄이기 위해 사용되며, 또한 대뇌 빈혈환자의 뇌 손상을 줄이고, 뇌사를 낮추기 위해 사용된다.
Contraindicated (one)pentobarbital will lower the extent or impact of lonafarnib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is often a sensitive CYP3A4 substrate. Coadministration with powerful or average CYP3A4 inducers is contraindicated.
pentobarbital boosts toxicity of buprenorphine, prolonged-performing injection by pharmacodynamic synergism. Modify Therapy/Watch Carefully. Coadministration of buprenorphine and benzodiazepines or other CNS depressants raises threat of adverse reactions like overdose, respiratory despair, and Loss of life. Cessation of benzodiazepines or other CNS depressants is desired generally.
pentobarbital will decrease the level or influence of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital will lower the level or impact of propafenone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Mysterious.